🕒 Friday 7 February 2025 Fri, 7 Feb 2025

Cleo Diagnostics has responded to an ASX price query following a notable rise in its share price and trading volume, underscoring its patented ovarian cancer detection technology and ongoing U.S. clinical trials.

Xstate Resources has divested its 25% stake in the Crest Jinn assets in Alberta, Canada, opting for a modest royalty interest as it refocuses amid geopolitical and operational uncertainties.

PM Capital Global Opportunities Fund has declared a 5.5 cent fully franked interim dividend for H1 FY25 and reaffirmed its commitment to an 11.0 cent annual dividend, supported by a 6.0% portfolio return for the year ending December 2024.

PM Capital Global Opportunities Fund Limited has announced a fully franked ordinary dividend of AUD 0.055 per security for the half-year ending December 2024, offering shareholders a Dividend Reinvestment Plan option.

PM Capital Global Opportunities Fund Limited reported an 11% rise in half-year profit to $39.8 million and declared a higher fully franked interim dividend of 5.5 cents per share, reflecting strong portfolio performance amid global market volatility.

E79 Gold Mines responds to ASX inquiries about recent price and volume spikes, linking market activity to a neighbour's gold find near its Laverton South Project.

Flagship Investments Limited posted a solid 9.1% gain in its investment portfolio for the half-year ending December 2024, despite a notable decline in total comprehensive income. The company declared a fully franked interim dividend of 5.1 cents per share, reflecting steady shareholder returns.

Cannindah Resources Limited has responded to an ASX price query, confirming no undisclosed information explains recent stock price movements and affirming compliance with continuous disclosure rules.

Helios Energy Ltd has secured A$691,325 through interest-free Convertible Notes to advance its Presidio Project in Texas, ensuring regulatory compliance and operational continuity.

360 Capital Mortgage REIT has updated the market with the payment of a 5.2 cent per unit distribution for January 2025, marking its first under the Attribution Managed Investment Trust (AMIT) regime.

The Supreme Court of Western Australia has approved the merger between Horizon Minerals and Poseidon Nickel, setting the stage for a significant consolidation in the nickel sector. Key dates for trading suspension and scheme implementation have now been confirmed.

Kaiser Reef Limited’s latest drilling at the Nova Zone within the A1 Gold Mine has revealed promising high-grade gold mineralisation, extending known reef systems and shaping future mine plans.

Citigroup Global Markets Australia has announced a fully franked dividend of AUD 1.10 for the REA Instalment MINI, with key dates set for early March 2025. This move aligns closely with the dividend schedule of the underlying REA Ordinary Security.

DMC Mining Limited has extended the closing date for its public share offer to May 8, 2025, due to delays in obtaining exploration licenses for its Firawa and Labe Projects in Guinea. The company plans to lodge a second supplementary prospectus to adjust regulatory conditions accordingly.

NT Minerals Limited reveals promising initial assay results from its Ultrafine Soil Sampling Program at the Twin Peaks Project, highlighting significant copper and gold anomalism that paves the way for targeted drilling in 2025.

The Australian Office of Financial Management has issued a new 4.25% Treasury Bond due in 2036, set to begin trading on the ASX from February 13, 2025. This issuance adds a fresh long-term government debt instrument to the market.

Neuren Pharmaceuticals has received a significant cash inflow of approximately US$50 million following the sale of a Priority Review Voucher linked to its Rett syndrome treatment. This milestone underscores the growing value of Neuren’s neurological drug portfolio and its partnership with Acadia Pharmaceuticals.

The Supreme Court of New South Wales has approved MyState Bank’s acquisition of Auswide Bank via a scheme of arrangement, setting the stage for a significant consolidation in the Australian banking sector.

Nyrada has secured ethics approval to begin its first-in-human Phase Ia trial of NYR-BI03, a promising neuro- and cardioprotective drug candidate. Recruitment starts soon, with dosing expected by March and results due in Q3 2025.

Iron Road Ltd has announced a strategic on-market share buy-back of up to 5% of its issued capital, aiming to enhance financial flexibility for its flagship projects over the next year.

Kalgoorlie Gold Mining has announced a significant new gold discovery named 'Lighthorse' at its Pinjin project, revealing thick, high-grade intercepts that promise to reshape its growth trajectory in the Eastern Goldfields. A follow-up drilling campaign is set for March 2025 to further delineate this expansive mineralised system.

Opyl Limited has entered a strategic partnership with Avion, integrating its AI-powered TrialKey platform to enhance clinical trial design and execution across the APAC region.

Sigma Healthcare has raised its FY25 normalised EBIT guidance to $64-$70 million, driven by robust operational performance and the successful rollout of a key supply contract with Chemist Warehouse.

Hartshead Resources has submitted a development programme and budget to the P2607 Joint Venture, proposing a new gas export route through CalEnergy’s Saturn Banks pipeline, promising reduced capital expenditure and accelerated production timelines.